Cargando…
Chronic N-Acetylcysteine Treatment Prevents Amphetamine-Induced Hyperactivity in Heterozygous Disc1 Mutant Mice, a Putative Prodromal Schizophrenia Animal Model
Symptoms of schizophrenia (SZ) typically emerge during adolescence to young adulthood, which gives a window before full-blown psychosis for early intervention. Strategies for preventing the conversion from the prodromal phase to the psychotic phase are warranted. Heterozygous (Het) Disc1 mutant mice...
Autores principales: | Lai, Chuan-Ching, Baskaran, Rathinasamy, Tsao, Chih-Yu, Tuan, Li-Heng, Siow, Pei-Fen, Palani, Mahalakshmi, Lee, Lukas Jyuhn-Hsiarn, Liu, Chih-Min, Hwu, Hai-Gwo, Lee, Li-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408838/ https://www.ncbi.nlm.nih.gov/pubmed/36012679 http://dx.doi.org/10.3390/ijms23169419 |
Ejemplares similares
-
Effects of N-acetylcysteine on amphetamine-induced sensitization in mice
por: Herrmann, Ana P., et al.
Publicado: (2017) -
Use of N-Acetylcysteine in Amphetamine-Induced Acute Liver Failure
por: Affas, Saif, et al.
Publicado: (2021) -
Methods to recognize work-related cancer in workplaces, the general population, and by experts in the clinic, a Norwegian experience
por: Langård, Sverre, et al.
Publicado: (2011) -
Chronic N-acetylcysteine treatment improves anhedonia and cognition in a mouse model of the schizophrenia prodrome
por: Bühner, Lukas Marius, et al.
Publicado: (2022) -
Amphetamines Improve the Motivation to Invest Effort in Attention-Deficit/Hyperactivity Disorder
por: Chong, Trevor T.-J., et al.
Publicado: (2023)